Curi Bio Names Nicholas A. Geisse, Ph.D., as New Chief Executive Officer
Read More
Curi Bio is proud to announce that Co-founder and Chief Business Officer Elliot Fisher has been listed as one of Forbes 30 Under 30 in healthcare.
In this 12th annual 30 Under 30 list, Forbes recognizes a set of tomorrow’s brightest young professionals in 20 separate categories, each of which showcase how the leaders are boldly tackling the problems of today.
Read More
Curi Bio Inc., a leading developer of human stem cell-based platforms for drug discovery, announced today it has raised $6 million in a Series A financing round.
Read More